e-learning
resources
Vienna 2012
Monday, 03.09.2012
Treatment of asthma, bronchiectasis and cough: inhaler use
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Safety and efficacy of ectoine inhalation solution in patients with inflammation and airway obstruction: The EFECT study
R. Berndt, U. Sydlik, A. Bilstein, A. Marini, T. Jaenicke, G. Seitner-Sorge, S. Stolz, J. Krutmann, U. Krämer, K. Unfried (Witten, Duesseldorf, Germany)
Source:
Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Session:
Treatment of asthma, bronchiectasis and cough: inhaler use
Session type:
Thematic Poster Session
Number:
2166
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Berndt, U. Sydlik, A. Bilstein, A. Marini, T. Jaenicke, G. Seitner-Sorge, S. Stolz, J. Krutmann, U. Krämer, K. Unfried (Witten, Duesseldorf, Germany). Safety and efficacy of ectoine inhalation solution in patients with inflammation and airway obstruction: The EFECT study. Eur Respir J 2012; 40: Suppl. 56, 2166
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Safety, dose finding and efficacy of ectoine inhalation solution in patients with mild asthma
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
A randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophils
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014
Safety of formoterol Turbuhaler(R) at cumulative dose of 90 {micro}g in patients with acute bronchial obstruction.
Source: Eur Respir J 2002; 19: 384
Year: 2002
Inhaled tobramycin for the prevention of airway stenosis after lung transplantation: A pilot study
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
A randomized phase 3 study of reslizumab efficacy in relation to blood eosinophil levels in patients with moderate to severe asthma
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014
Efficacy of bronchial thermoplasty (BT) in patients with severe asthma: the AIR2 trial
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Acute tracheobronchitis in children: airway inflammation objective monitoring trial
Source: Eur Respir J 2007; 30: Suppl. 51, 366s
Year: 2007
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Source: Eur Respir J 2007; 30: 457-466
Year: 2007
Feasibility and safety evaluation of Simeox airway clearance technique (ACT) in patients with bronchiectasis
Source: International Congress 2019 – Highlights in lung function and chronic cough
Year: 2019
Efficacy and safety of aclidinium/formoterol fixed-dose combination in patients with moderate to severe airflow obstruction, stratified by severity
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Airway inflammation objective monitoring trial: challenge in infants with bronchiolitis
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008
Safety and efficacy of inhaled mannitol as a bronchial provocation test in children
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Montelukast attenuates the airway response to hypertonic saline in moderate-to-severe COPD
Source: Eur Respir J 2003 Dec 01;22(6):926-930
Year: 2003
Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Safety of airway clearance techniques, sputum induction and bronchoscopy in severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017
Inhaled corticosteroids in patients with mild to moderate COPD with and without airway hyperresponsiveness to mannitol: A randomized placebo controlled trial
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Efficacy of symbicort administration in patients with bronchial asthma
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Study of the Glutoxim-containing inhalation treatment in bronchial asthma patients
Source: Eur Respir J 2002; 20: Suppl. 38, 373s
Year: 2002
Study design supporting the effectiveness of inhaled extra-fine beclomethasone/formoterol at the level of small airways of asthmatics
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept